Wenes, M., Jaccard, A., Wyss, T., Maldonado-Pérez, N., Teoh, S., Lepez, A., . . . Romero, P. (2021). 47MO Metabolic intervention during CAR T-cell manufacturing improves persistence and antitumor efficacy. Annals of Oncology, 32, S1393. https://doi.org/10.1016/j.annonc.2021.10.064
Chicago Style (17th ed.) CitationWenes, M., et al. "47MO Metabolic Intervention During CAR T-cell Manufacturing Improves Persistence and Antitumor Efficacy." Annals of Oncology 32 (2021): S1393. https://doi.org/10.1016/j.annonc.2021.10.064.
MLA (9th ed.) CitationWenes, M., et al. "47MO Metabolic Intervention During CAR T-cell Manufacturing Improves Persistence and Antitumor Efficacy." Annals of Oncology, vol. 32, 2021, p. S1393, https://doi.org/10.1016/j.annonc.2021.10.064.